1 Market Overview

1.1 Product Overview and Scope of Liver Diseases Treatment

1.2 Classification of Liver Diseases Treatment by Type

1.2.1 Overview: Global Liver Diseases Treatment Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Liver Diseases Treatment Revenue Market Share by Type in 2020

1.2.3 Chemotherapy Drugs

1.2.4 Targeted Therapy

1.2.5 Anti-Viral Drugs

1.2.6 Immunoglobulins

1.2.7 Corticosteroids

1.2.8 Vaccines

1.2.9 Anti-Rejection Drugs/Immunosuppressant

1.3 Global Liver Diseases Treatment Market by Application

1.3.1 Overview: Global Liver Diseases Treatment Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Cancer

1.3.3 Hepatitis

1.3.4 Cirrhosis

1.3.5 Other

1.4 Global Liver Diseases Treatment Market Size & Forecast

1.5 Global Liver Diseases Treatment Market Size and Forecast by Region

1.5.1 Global Liver Diseases Treatment Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Liver Diseases Treatment Market Size by Region, (2016-2021)

1.5.3 North America Liver Diseases Treatment Market Size and Prospect (2016-2026)

1.5.4 Europe Liver Diseases Treatment Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Liver Diseases Treatment Market Size and Prospect (2016-2026)

1.5.6 South America Liver Diseases Treatment Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Liver Diseases Treatment Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Liver Diseases Treatment Market Drivers

1.6.2 Liver Diseases Treatment Market Restraints

1.6.3 Liver Diseases Treatment Trends Analysis

2 Company Profiles

2.1 Abbott Laboratories

2.1.1 Abbott Laboratories Details

2.1.2 Abbott Laboratories Major Business

2.1.3 Abbott Laboratories Liver Diseases Treatment Product and Solutions

2.1.4 Abbott Laboratories Liver Diseases Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Abbott Laboratories Recent Developments and Future Plans

2.2 Bayer Schering

2.2.1 Bayer Schering Details

2.2.2 Bayer Schering Major Business

2.2.3 Bayer Schering Liver Diseases Treatment Product and Solutions

2.2.4 Bayer Schering Liver Diseases Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Bayer Schering Recent Developments and Future Plans

2.3 Eli Lilly

2.3.1 Eli Lilly Details

2.3.2 Eli Lilly Major Business

2.3.3 Eli Lilly Liver Diseases Treatment Product and Solutions

2.3.4 Eli Lilly Liver Diseases Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Eli Lilly Recent Developments and Future Plans

2.4 Merck

2.4.1 Merck Details

2.4.2 Merck Major Business

2.4.3 Merck Liver Diseases Treatment Product and Solutions

2.4.4 Merck Liver Diseases Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Merck Recent Developments and Future Plans

2.5 Novartis

2.5.1 Novartis Details

2.5.2 Novartis Major Business

2.5.3 Novartis Liver Diseases Treatment Product and Solutions

2.5.4 Novartis Liver Diseases Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Novartis Recent Developments and Future Plans

2.6 Pfizer

2.6.1 Pfizer Details

2.6.2 Pfizer Major Business

2.6.3 Pfizer Liver Diseases Treatment Product and Solutions

2.6.4 Pfizer Liver Diseases Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Pfizer Recent Developments and Future Plans

2.7 Roche

2.7.1 Roche Details

2.7.2 Roche Major Business

2.7.3 Roche Liver Diseases Treatment Product and Solutions

2.7.4 Roche Liver Diseases Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Roche Recent Developments and Future Plans

2.8 Sanofi-Aventis

2.8.1 Sanofi-Aventis Details

2.8.2 Sanofi-Aventis Major Business

2.8.3 Sanofi-Aventis Liver Diseases Treatment Product and Solutions

2.8.4 Sanofi-Aventis Liver Diseases Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Sanofi-Aventis Recent Developments and Future Plans

2.9 Takeda Pharmaceutical

2.9.1 Takeda Pharmaceutical Details

2.9.2 Takeda Pharmaceutical Major Business

2.9.3 Takeda Pharmaceutical Liver Diseases Treatment Product and Solutions

2.9.4 Takeda Pharmaceutical Liver Diseases Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Takeda Pharmaceutical Recent Developments and Future Plans

2.10 Zydus Pharmaceuticals

2.10.1 Zydus Pharmaceuticals Details

2.10.2 Zydus Pharmaceuticals Major Business

2.10.3 Zydus Pharmaceuticals Liver Diseases Treatment Product and Solutions

2.10.4 Zydus Pharmaceuticals Liver Diseases Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Zydus Pharmaceuticals Recent Developments and Future Plans

2.11 Glaxosmithkline

2.11.1 Glaxosmithkline Details

2.11.2 Glaxosmithkline Major Business

2.11.3 Glaxosmithkline Liver Diseases Treatment Product and Solutions

2.11.4 Glaxosmithkline Liver Diseases Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Glaxosmithkline Recent Developments and Future Plans

2.12 Bristol-Myers Squibb

2.12.1 Bristol-Myers Squibb Details

2.12.2 Bristol-Myers Squibb Major Business

2.12.3 Bristol-Myers Squibb Liver Diseases Treatment Product and Solutions

2.12.4 Bristol-Myers Squibb Liver Diseases Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 Bristol-Myers Squibb Recent Developments and Future Plans

2.13 General Electric

2.13.1 General Electric Details

2.13.2 General Electric Major Business

2.13.3 General Electric Liver Diseases Treatment Product and Solutions

2.13.4 General Electric Liver Diseases Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 General Electric Recent Developments and Future Plans

2.14 Koninklijke Philips

2.14.1 Koninklijke Philips Details

2.14.2 Koninklijke Philips Major Business

2.14.3 Koninklijke Philips Liver Diseases Treatment Product and Solutions

2.14.4 Koninklijke Philips Liver Diseases Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 Koninklijke Philips Recent Developments and Future Plans

2.15 Siemens

2.15.1 Siemens Details

2.15.2 Siemens Major Business

2.15.3 Siemens Liver Diseases Treatment Product and Solutions

2.15.4 Siemens Liver Diseases Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.15.5 Siemens Recent Developments and Future Plans

2.16 Canon Medical Systems Corp

2.16.1 Canon Medical Systems Corp Details

2.16.2 Canon Medical Systems Corp Major Business

2.16.3 Canon Medical Systems Corp Liver Diseases Treatment Product and Solutions

2.16.4 Canon Medical Systems Corp Liver Diseases Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.16.5 Canon Medical Systems Corp Recent Developments and Future Plans

2.17 Hitachi

2.17.1 Hitachi Details

2.17.2 Hitachi Major Business

2.17.3 Hitachi Liver Diseases Treatment Product and Solutions

2.17.4 Hitachi Liver Diseases Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.17.5 Hitachi Recent Developments and Future Plans

2.18 Elekta

2.18.1 Elekta Details

2.18.2 Elekta Major Business

2.18.3 Elekta Liver Diseases Treatment Product and Solutions

2.18.4 Elekta Liver Diseases Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.18.5 Elekta Recent Developments and Future Plans

2.19 Neusoft Corporation

2.19.1 Neusoft Corporation Details

2.19.2 Neusoft Corporation Major Business

2.19.3 Neusoft Corporation Liver Diseases Treatment Product and Solutions

2.19.4 Neusoft Corporation Liver Diseases Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.19.5 Neusoft Corporation Recent Developments and Future Plans

2.20 Samsung Healthcare

2.20.1 Samsung Healthcare Details

2.20.2 Samsung Healthcare Major Business

2.20.3 Samsung Healthcare Liver Diseases Treatment Product and Solutions

2.20.4 Samsung Healthcare Liver Diseases Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.20.5 Samsung Healthcare Recent Developments and Future Plans

2.21 BPL Medical Technologies

2.21.1 BPL Medical Technologies Details

2.21.2 BPL Medical Technologies Major Business

2.21.3 BPL Medical Technologies Liver Diseases Treatment Product and Solutions

2.21.4 BPL Medical Technologies Liver Diseases Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.21.5 BPL Medical Technologies Recent Developments and Future Plans

2.22 Cura Healthcare

2.22.1 Cura Healthcare Details

2.22.2 Cura Healthcare Major Business

2.22.3 Cura Healthcare Liver Diseases Treatment Product and Solutions

2.22.4 Cura Healthcare Liver Diseases Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.22.5 Cura Healthcare Recent Developments and Future Plans

2.23 Angion Biomedica

2.23.1 Angion Biomedica Details

2.23.2 Angion Biomedica Major Business

2.23.3 Angion Biomedica Liver Diseases Treatment Product and Solutions

2.23.4 Angion Biomedica Liver Diseases Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.23.5 Angion Biomedica Recent Developments and Future Plans

2.24 Achillion Pharmaceuticals

2.24.1 Achillion Pharmaceuticals Details

2.24.2 Achillion Pharmaceuticals Major Business

2.24.3 Achillion Pharmaceuticals Liver Diseases Treatment Product and Solutions

2.24.4 Achillion Pharmaceuticals Liver Diseases Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.24.5 Achillion Pharmaceuticals Recent Developments and Future Plans

2.25 Gilead Sciences

2.25.1 Gilead Sciences Details

2.25.2 Gilead Sciences Major Business

2.25.3 Gilead Sciences Liver Diseases Treatment Product and Solutions

2.25.4 Gilead Sciences Liver Diseases Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.25.5 Gilead Sciences Recent Developments and Future Plans

2.26 LG Life Sciences

2.26.1 LG Life Sciences Details

2.26.2 LG Life Sciences Major Business

2.26.3 LG Life Sciences Liver Diseases Treatment Product and Solutions

2.26.4 LG Life Sciences Liver Diseases Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.26.5 LG Life Sciences Recent Developments and Future Plans

2.27 Verva Pharmaceuticals

2.27.1 Verva Pharmaceuticals Details

2.27.2 Verva Pharmaceuticals Major Business

2.27.3 Verva Pharmaceuticals Liver Diseases Treatment Product and Solutions

2.27.4 Verva Pharmaceuticals Liver Diseases Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.27.5 Verva Pharmaceuticals Recent Developments and Future Plans

2.28 Shenzhen Kangtai Biological Products

2.28.1 Shenzhen Kangtai Biological Products Details

2.28.2 Shenzhen Kangtai Biological Products Major Business

2.28.3 Shenzhen Kangtai Biological Products Liver Diseases Treatment Product and Solutions

2.28.4 Shenzhen Kangtai Biological Products Liver Diseases Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.28.5 Shenzhen Kangtai Biological Products Recent Developments and Future Plans

2.29 Raptor Pharmaceuticals

2.29.1 Raptor Pharmaceuticals Details

2.29.2 Raptor Pharmaceuticals Major Business

2.29.3 Raptor Pharmaceuticals Liver Diseases Treatment Product and Solutions

2.29.4 Raptor Pharmaceuticals Liver Diseases Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.29.5 Raptor Pharmaceuticals Recent Developments and Future Plans

2.30 ProMetic Life Sciences

2.30.1 ProMetic Life Sciences Details

2.30.2 ProMetic Life Sciences Major Business

2.30.3 ProMetic Life Sciences Liver Diseases Treatment Product and Solutions

2.30.4 ProMetic Life Sciences Liver Diseases Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.30.5 ProMetic Life Sciences Recent Developments and Future Plans

2.31 Phenex Pharmaceuticals

2.31.1 Phenex Pharmaceuticals Details

2.31.2 Phenex Pharmaceuticals Major Business

2.31.3 Phenex Pharmaceuticals Liver Diseases Treatment Product and Solutions

2.31.4 Phenex Pharmaceuticals Liver Diseases Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.31.5 Phenex Pharmaceuticals Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Liver Diseases Treatment Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Liver Diseases Treatment Players Market Share

3.2.2 Top 10 Liver Diseases Treatment Players Market Share

3.2.3 Market Competition Trend

3.3 Liver Diseases Treatment Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Liver Diseases Treatment Revenue and Market Share by Type (2016-2021)

4.2 Global Liver Diseases Treatment Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Liver Diseases Treatment Revenue Market Share by Application (2016-2021)

5.2 Liver Diseases Treatment Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Liver Diseases Treatment Revenue by Type (2016-2026)

6.2 North America Liver Diseases Treatment Revenue by Application (2016-2026)

6.3 North America Liver Diseases Treatment Market Size by Country

6.3.1 North America Liver Diseases Treatment Revenue by Country (2016-2026)

6.3.2 United States Liver Diseases Treatment Market Size and Forecast (2016-2026)

6.3.3 Canada Liver Diseases Treatment Market Size and Forecast (2016-2026)

6.3.4 Mexico Liver Diseases Treatment Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Liver Diseases Treatment Revenue by Type (2016-2026)

7.2 Europe Liver Diseases Treatment Revenue by Application (2016-2026)

7.3 Europe Liver Diseases Treatment Market Size by Country

7.3.1 Europe Liver Diseases Treatment Revenue by Country (2016-2026)

7.3.2 Germany Liver Diseases Treatment Market Size and Forecast (2016-2026)

7.3.3 France Liver Diseases Treatment Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Liver Diseases Treatment Market Size and Forecast (2016-2026)

7.3.5 Russia Liver Diseases Treatment Market Size and Forecast (2016-2026)

7.3.6 Italy Liver Diseases Treatment Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Liver Diseases Treatment Revenue by Type (2016-2026)

8.2 Asia-Pacific Liver Diseases Treatment Revenue by Application (2016-2026)

8.3 Asia-Pacific Liver Diseases Treatment Market Size by Region

8.3.1 Asia-Pacific Liver Diseases Treatment Revenue by Region (2016-2026)

8.3.2 China Liver Diseases Treatment Market Size and Forecast (2016-2026)

8.3.3 Japan Liver Diseases Treatment Market Size and Forecast (2016-2026)

8.3.4 South Korea Liver Diseases Treatment Market Size and Forecast (2016-2026)

8.3.5 India Liver Diseases Treatment Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Liver Diseases Treatment Market Size and Forecast (2016-2026)

8.3.7 Australia Liver Diseases Treatment Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Liver Diseases Treatment Revenue by Type (2016-2026)

9.2 South America Liver Diseases Treatment Revenue by Application (2016-2026)

9.3 South America Liver Diseases Treatment Market Size by Country

9.3.1 South America Liver Diseases Treatment Revenue by Country (2016-2026)

9.3.2 Brazil Liver Diseases Treatment Market Size and Forecast (2016-2026)

9.3.3 Argentina Liver Diseases Treatment Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Liver Diseases Treatment Revenue by Type (2016-2026)

10.2 Middle East & Africa Liver Diseases Treatment Revenue by Application (2016-2026)

10.3 Middle East & Africa Liver Diseases Treatment Market Size by Country

10.3.1 Middle East & Africa Liver Diseases Treatment Revenue by Country (2016-2026)

10.3.2 Turkey Liver Diseases Treatment Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Liver Diseases Treatment Market Size and Forecast (2016-2026)

10.3.4 UAE Liver Diseases Treatment Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Liver Diseases Treatment Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Liver Diseases Treatment Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Liver Diseases Treatment Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Liver Diseases Treatment Revenue (USD Million) by Region (2016-2021)

Table 5. Global Liver Diseases Treatment Revenue Market Share by Region (2021-2026)

Table 6. Abbott Laboratories Corporate Information, Head Office, and Major Competitors

Table 7. Abbott Laboratories Major Business

Table 8. Abbott Laboratories Liver Diseases Treatment Product and Solutions

Table 9. Abbott Laboratories Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Bayer Schering Corporate Information, Head Office, and Major Competitors

Table 11. Bayer Schering Major Business

Table 12. Bayer Schering Liver Diseases Treatment Product and Solutions

Table 13. Bayer Schering Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Eli Lilly Corporate Information, Head Office, and Major Competitors

Table 15. Eli Lilly Major Business

Table 16. Eli Lilly Liver Diseases Treatment Product and Solutions

Table 17. Eli Lilly Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Merck Corporate Information, Head Office, and Major Competitors

Table 19. Merck Major Business

Table 20. Merck Liver Diseases Treatment Product and Solutions

Table 21. Merck Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Novartis Corporate Information, Head Office, and Major Competitors

Table 23. Novartis Major Business

Table 24. Novartis Liver Diseases Treatment Product and Solutions

Table 25. Novartis Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Pfizer Corporate Information, Head Office, and Major Competitors

Table 27. Pfizer Major Business

Table 28. Pfizer Liver Diseases Treatment Product and Solutions

Table 29. Pfizer Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Roche Corporate Information, Head Office, and Major Competitors

Table 31. Roche Major Business

Table 32. Roche Liver Diseases Treatment Product and Solutions

Table 33. Roche Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Sanofi-Aventis Corporate Information, Head Office, and Major Competitors

Table 35. Sanofi-Aventis Major Business

Table 36. Sanofi-Aventis Liver Diseases Treatment Product and Solutions

Table 37. Sanofi-Aventis Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Takeda Pharmaceutical Corporate Information, Head Office, and Major Competitors

Table 39. Takeda Pharmaceutical Major Business

Table 40. Takeda Pharmaceutical Liver Diseases Treatment Product and Solutions

Table 41. Takeda Pharmaceutical Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Zydus Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 43. Zydus Pharmaceuticals Major Business

Table 44. Zydus Pharmaceuticals Liver Diseases Treatment Product and Solutions

Table 45. Zydus Pharmaceuticals Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Glaxosmithkline Corporate Information, Head Office, and Major Competitors

Table 47. Glaxosmithkline Major Business

Table 48. Glaxosmithkline Liver Diseases Treatment Product and Solutions

Table 49. Glaxosmithkline Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. Bristol-Myers Squibb Corporate Information, Head Office, and Major Competitors

Table 51. Bristol-Myers Squibb Major Business

Table 52. Bristol-Myers Squibb Liver Diseases Treatment Product and Solutions

Table 53. Bristol-Myers Squibb Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. General Electric Corporate Information, Head Office, and Major Competitors

Table 55. General Electric Major Business

Table 56. General Electric Liver Diseases Treatment Product and Solutions

Table 57. General Electric Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. Koninklijke Philips Corporate Information, Head Office, and Major Competitors

Table 59. Koninklijke Philips Major Business

Table 60. Koninklijke Philips Liver Diseases Treatment Product and Solutions

Table 61. Koninklijke Philips Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 62. Siemens Corporate Information, Head Office, and Major Competitors

Table 63. Siemens Major Business

Table 64. Siemens Liver Diseases Treatment Product and Solutions

Table 65. Siemens Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 66. Canon Medical Systems Corp Corporate Information, Head Office, and Major Competitors

Table 67. Canon Medical Systems Corp Major Business

Table 68. Canon Medical Systems Corp Liver Diseases Treatment Product and Solutions

Table 69. Canon Medical Systems Corp Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 70. Hitachi Corporate Information, Head Office, and Major Competitors

Table 71. Hitachi Major Business

Table 72. Hitachi Liver Diseases Treatment Product and Solutions

Table 73. Hitachi Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 74. Elekta Corporate Information, Head Office, and Major Competitors

Table 75. Elekta Major Business

Table 76. Elekta Liver Diseases Treatment Product and Solutions

Table 77. Elekta Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 78. Neusoft Corporation Corporate Information, Head Office, and Major Competitors

Table 79. Neusoft Corporation Major Business

Table 80. Neusoft Corporation Liver Diseases Treatment Product and Solutions

Table 81. Neusoft Corporation Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 82. Samsung Healthcare Corporate Information, Head Office, and Major Competitors

Table 83. Samsung Healthcare Major Business

Table 84. Samsung Healthcare Liver Diseases Treatment Product and Solutions

Table 85. Samsung Healthcare Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 86. BPL Medical Technologies Corporate Information, Head Office, and Major Competitors

Table 87. BPL Medical Technologies Major Business

Table 88. BPL Medical Technologies Liver Diseases Treatment Product and Solutions

Table 89. BPL Medical Technologies Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 90. Cura Healthcare Corporate Information, Head Office, and Major Competitors

Table 91. Cura Healthcare Major Business

Table 92. Cura Healthcare Liver Diseases Treatment Product and Solutions

Table 93. Cura Healthcare Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 94. Angion Biomedica Corporate Information, Head Office, and Major Competitors

Table 95. Angion Biomedica Major Business

Table 96. Angion Biomedica Liver Diseases Treatment Product and Solutions

Table 97. Angion Biomedica Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 98. Achillion Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 99. Achillion Pharmaceuticals Major Business

Table 100. Achillion Pharmaceuticals Liver Diseases Treatment Product and Solutions

Table 101. Achillion Pharmaceuticals Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 102. Gilead Sciences Corporate Information, Head Office, and Major Competitors

Table 103. Gilead Sciences Major Business

Table 104. Gilead Sciences Liver Diseases Treatment Product and Solutions

Table 105. Gilead Sciences Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 106. LG Life Sciences Corporate Information, Head Office, and Major Competitors

Table 107. LG Life Sciences Major Business

Table 108. LG Life Sciences Liver Diseases Treatment Product and Solutions

Table 109. LG Life Sciences Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 110. Verva Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 111. Verva Pharmaceuticals Major Business

Table 112. Verva Pharmaceuticals Liver Diseases Treatment Product and Solutions

Table 113. Verva Pharmaceuticals Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 114. Shenzhen Kangtai Biological Products Corporate Information, Head Office, and Major Competitors

Table 115. Shenzhen Kangtai Biological Products Major Business

Table 116. Shenzhen Kangtai Biological Products Liver Diseases Treatment Product and Solutions

Table 117. Shenzhen Kangtai Biological Products Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 118. Raptor Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 119. Raptor Pharmaceuticals Major Business

Table 120. Raptor Pharmaceuticals Liver Diseases Treatment Product and Solutions

Table 121. Raptor Pharmaceuticals Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 122. ProMetic Life Sciences Corporate Information, Head Office, and Major Competitors

Table 123. ProMetic Life Sciences Major Business

Table 124. ProMetic Life Sciences Liver Diseases Treatment Product and Solutions

Table 125. ProMetic Life Sciences Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 126. Global Liver Diseases Treatment Revenue (USD Million) by Players (2019-2021)

Table 127. Global Liver Diseases Treatment Revenue Share by Players (2019-2021)

Table 128. Breakdown of Liver Diseases Treatment by Company Type (Tier 1, Tier 2 and Tier 3)

Table 129. Liver Diseases Treatment Players Head Office, Products and Services Provided

Table 130. Liver Diseases Treatment Mergers & Acquisitions in the Past Five Years

Table 131. Liver Diseases Treatment New Entrants and Expansion Plans

Table 132. Global Liver Diseases Treatment Revenue (USD Million) by Type (2016-2021)

Table 133. Global Liver Diseases Treatment Revenue Share by Type (2016-2021)

Table 134. Global Liver Diseases Treatment Revenue Forecast by Type (2021-2026)

Table 135. Global Liver Diseases Treatment Revenue by Application (2016-2021)

Table 136. Global Liver Diseases Treatment Revenue Forecast by Application (2021-2026)

Table 137. North America Liver Diseases Treatment Revenue by Type (2016-2021) & (USD Million)

Table 138. North America Liver Diseases Treatment Revenue by Type (2021-2026) & (USD Million)

Table 139. North America Liver Diseases Treatment Revenue by Application (2016-2021) & (USD Million)

Table 140. North America Liver Diseases Treatment Revenue by Application (2021-2026) & (USD Million)

Table 141. North America Liver Diseases Treatment Revenue by Country (2016-2021) & (USD Million)

Table 142. North America Liver Diseases Treatment Revenue by Country (2021-2026) & (USD Million)

Table 143. Europe Liver Diseases Treatment Revenue by Type (2016-2021) & (USD Million)

Table 144. Europe Liver Diseases Treatment Revenue by Type (2021-2026) & (USD Million)

Table 145. Europe Liver Diseases Treatment Revenue by Application (2016-2021) & (USD Million)

Table 146. Europe Liver Diseases Treatment Revenue by Application (2021-2026) & (USD Million)

Table 147. Europe Liver Diseases Treatment Revenue by Country (2016-2021) & (USD Million)

Table 148. Europe Liver Diseases Treatment Revenue by Country (2021-2026) & (USD Million)

Table 149. Asia-Pacific Liver Diseases Treatment Revenue by Type (2016-2021) & (USD Million)

Table 150. Asia-Pacific Liver Diseases Treatment Revenue by Type (2021-2026) & (USD Million)

Table 151. Asia-Pacific Liver Diseases Treatment Revenue by Application (2016-2021) & (USD Million)

Table 152. Asia-Pacific Liver Diseases Treatment Revenue by Application (2021-2026) & (USD Million)

Table 153. Asia-Pacific Liver Diseases Treatment Revenue by Region (2016-2021) & (USD Million)

Table 154. Asia-Pacific Liver Diseases Treatment Revenue by Region (2021-2026) & (USD Million)

Table 155. South America Liver Diseases Treatment Revenue by Type (2016-2021) & (USD Million)

Table 156. South America Liver Diseases Treatment Revenue by Type (2021-2026) & (USD Million)

Table 157. South America Liver Diseases Treatment Revenue by Application (2016-2021) & (USD Million)

Table 158. South America Liver Diseases Treatment Revenue by Application (2021-2026) & (USD Million)

Table 159. South America Liver Diseases Treatment Revenue by Country (2016-2021) & (USD Million)

Table 160. South America Liver Diseases Treatment Revenue by Country (2021-2026) & (USD Million)

Table 161. Middle East & Africa Liver Diseases Treatment Revenue by Type (2016-2021) & (USD Million)

Table 162. Middle East & Africa Liver Diseases Treatment Revenue by Type (2021-2026) & (USD Million)

Table 163. Middle East & Africa Liver Diseases Treatment Revenue by Application (2016-2021) & (USD Million)

Table 164. Middle East & Africa Liver Diseases Treatment Revenue by Application (2021-2026) & (USD Million)

Table 165. Middle East & Africa Liver Diseases Treatment Revenue by Country (2016-2021) & (USD Million)

Table 166. Middle East & Africa Liver Diseases Treatment Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Liver Diseases Treatment Picture

Figure 2. Global Liver Diseases Treatment Revenue Market Share by Type in 2020

Figure 3. Chemotherapy Drugs

Figure 4. Targeted Therapy

Figure 5. Anti-Viral Drugs

Figure 6. Immunoglobulins

Figure 7. Corticosteroids

Figure 8. Vaccines

Figure 9. Anti-Rejection Drugs/Immunosuppressant

Figure 10. Liver Diseases Treatment Revenue Market Share by Application in 2020

Figure 11. Cancer Picture

Figure 12. Hepatitis Picture

Figure 13. Cirrhosis Picture

Figure 14. Other Picture

Figure 15. Global Liver Diseases Treatment Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 16. Global Liver Diseases Treatment Revenue and Forecast (2016-2026) & (USD Million)

Figure 17. Global Liver Diseases Treatment Revenue Market Share by Region (2016-2026)

Figure 18. Global Liver Diseases Treatment Revenue Market Share by Region in 2020

Figure 19. North America Liver Diseases Treatment Revenue (USD Million) and Growth Rate (2016-2026)

Figure 20. Europe Liver Diseases Treatment Revenue (USD Million) and Growth Rate (2016-2026)

Figure 21. Asia-Pacific Liver Diseases Treatment Revenue (USD Million) and Growth Rate (2016-2026)

Figure 22. South America Liver Diseases Treatment Revenue (USD Million) and Growth Rate (2016-2026)

Figure 23. Middle East and Africa Liver Diseases Treatment Revenue (USD Million) and Growth Rate (2016-2026)

Figure 24. Liver Diseases Treatment Market Drivers

Figure 25. Liver Diseases Treatment Market Restraints

Figure 26. Liver Diseases Treatment Market Trends

Figure 27. Abbott Laboratories Recent Developments and Future Plans

Figure 28. Bayer Schering Recent Developments and Future Plans

Figure 29. Eli Lilly Recent Developments and Future Plans

Figure 30. Merck Recent Developments and Future Plans

Figure 31. Novartis Recent Developments and Future Plans

Figure 32. Pfizer Recent Developments and Future Plans

Figure 33. Roche Recent Developments and Future Plans

Figure 34. Sanofi-Aventis Recent Developments and Future Plans

Figure 35. Takeda Pharmaceutical Recent Developments and Future Plans

Figure 36. Zydus Pharmaceuticals Recent Developments and Future Plans

Figure 37. Glaxosmithkline Recent Developments and Future Plans

Figure 38. Bristol-Myers Squibb Recent Developments and Future Plans

Figure 39. General Electric Recent Developments and Future Plans

Figure 40. Koninklijke Philips Recent Developments and Future Plans

Figure 41. Siemens Recent Developments and Future Plans

Figure 42. Canon Medical Systems Corp Recent Developments and Future Plans

Figure 43. Hitachi Recent Developments and Future Plans

Figure 44. Elekta Recent Developments and Future Plans

Figure 45. Neusoft Corporation Recent Developments and Future Plans

Figure 46. Samsung Healthcare Recent Developments and Future Plans

Figure 47. BPL Medical Technologies Recent Developments and Future Plans

Figure 48. Cura Healthcare Recent Developments and Future Plans

Figure 49. Angion Biomedica Recent Developments and Future Plans

Figure 50. Achillion Pharmaceuticals Recent Developments and Future Plans

Figure 51. Gilead Sciences Recent Developments and Future Plans

Figure 52. LG Life Sciences Recent Developments and Future Plans

Figure 53. Verva Pharmaceuticals Recent Developments and Future Plans

Figure 54. Shenzhen Kangtai Biological Products Recent Developments and Future Plans

Figure 55. Raptor Pharmaceuticals Recent Developments and Future Plans

Figure 56. ProMetic Life Sciences Recent Developments and Future Plans

Figure 57. Phenex Pharmaceuticals Recent Developments and Future Plans

Figure 58. Global Liver Diseases Treatment Revenue Share by Players in 2020

Figure 59. Liver Diseases Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 60. Global Top 3 Players Liver Diseases Treatment Revenue Market Share in 2020

Figure 61. Global Top 10 Players Liver Diseases Treatment Revenue Market Share in 2020

Figure 62. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 63. Global Liver Diseases Treatment Revenue Share by Type in 2020

Figure 64. Global Liver Diseases Treatment Market Share Forecast by Type (2021-2026)

Figure 65. Global Liver Diseases Treatment Revenue Share by Application in 2020

Figure 66. Global Liver Diseases Treatment Market Share Forecast by Application (2021-2026)

Figure 67. North America Liver Diseases Treatment Sales Market Share by Type (2016-2026)

Figure 68. North America Liver Diseases Treatment Sales Market Share by Application (2016-2026)

Figure 69. North America Liver Diseases Treatment Revenue Market Share by Country (2016-2026)

Figure 70. United States Liver Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. Canada Liver Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. Mexico Liver Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. Europe Liver Diseases Treatment Sales Market Share by Type (2016-2026)

Figure 74. Europe Liver Diseases Treatment Sales Market Share by Application (2016-2026)

Figure 75. Europe Liver Diseases Treatment Revenue Market Share by Country (2016-2026)

Figure 76. Germany Liver Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. France Liver Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 78. United Kingdom Liver Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 79. Russia Liver Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 80. Italy Liver Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 81. Asia-Pacific Liver Diseases Treatment Sales Market Share by Type (2016-2026)

Figure 82. Asia-Pacific Liver Diseases Treatment Sales Market Share by Application (2016-2026)

Figure 83. Asia-Pacific Liver Diseases Treatment Revenue Market Share by Region (2016-2026)

Figure 84. China Liver Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 85. Japan Liver Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 86. South Korea Liver Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 87. India Liver Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 88. Southeast Asia Liver Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 89. Australia Liver Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 90. South America Liver Diseases Treatment Sales Market Share by Type (2016-2026)

Figure 91. South America Liver Diseases Treatment Sales Market Share by Application (2016-2026)

Figure 92. South America Liver Diseases Treatment Revenue Market Share by Country (2016-2026)

Figure 93. Brazil Liver Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 94. Argentina Liver Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 95. Middle East and Africa Liver Diseases Treatment Sales Market Share by Type (2016-2026)

Figure 96. Middle East and Africa Liver Diseases Treatment Sales Market Share by Application (2016-2026)

Figure 97. Middle East and Africa Liver Diseases Treatment Revenue Market Share by Country (2016-2026)

Figure 98. Turkey Liver Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 99. Saudi Arabia Liver Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 100. UAE Liver Diseases Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 101. Methodology

Figure 102. Research Process and Data Source